HINJ-CHI Alzheimer's Disease Congressional Briefing

The cost to America's economy to care for individuals with Alzheimer's disease is $172 billion per year.

It is estimated that by 2050, 13.5 million Americans will have some form of dementia, including Alzheimer's disease.

If no treatment is found the cost to our economy is expected to climb as high as $1 trillion per year.

Recently the HealthCare Institute of New Jersey and the California HealthCare Institute hosted a congressional briefing to facilitate a dialogue about Alzheimer's disease research. This program included an overview of advances stemming from California's and New Jersey's life sciences sectors, with an expert panel discussing current research and drug development, as well as future discoveries.

Participants includes Rep. Chris Smith (R-N.J.); Rep. Linda Sanchez (D-Calif.); David Gollaher, Ph.D., CHI President and CEO; Dean Paranicas, HINJ President and CEO; Joseph Hammang, Ph.D., senior director of worldwide science policy at Pfizer; Dr. Stuart Lipton, director of Sanford-Burnham's Del E. Webb Neuroscience, Aging and Stem Cell Research Center; Bob Nelson, Ph.D., research fellow with Lundbeck Research USA; Wayne Poon, Ph.D., director of UC Irvine's MIND Brain Bank and Tissue Repository; and Kimberly Scearce-Levie, Ph.D., head of in vivo neurobiology at Genentech Inc.

Category:

Science & Technology

Tags:

• HINJ
• Alzheimer's
• disease